ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Incidence and survival of epithelial salivary glands cancer by tumor site and histology in Tarragona and Girona, Catalonia, Spain.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMalignant neoplasms of the salivary glands are a heterogeneous group of cancers that include more than 24 malignant histological types in the salivary glands, with different genetic, morphological, and immunohistochemical features and clinical behavior. MATERIALS AND
methodsA retrospective population-based analysis of salivary gland cancers diagnosed between 1994 and 2018 was performed, using data from the Girona and Tarragona cancer registries. Crude incidence rates, European and world-age-standardized incidence rates and incidence trends, measured as the annual percentage change, were estimated. Observed and net survival at 5 and 10 years and 10-y/5-y conditional survival were calculated. The analysis was focused on histological type.
resultsA total of 301 cases were recorded in the provinces of Girona and Tarragona during 1994-2018, of which 51.5% were in men and 76.1% in the parotid salivary gland. The most common histology type was the squamous cell carcinoma (17.9%) followed by the mucoepidermoid carcinoma (16.9%). Incidence was 9.2 cases per 1,000,000 person-years for all salivary gland tumors. A decrease in incidence for all cases and in most of the histology types specifically, was observed. For the cohort, the 10-year observed and net survival rates were 37.3 and 55.5%, respectively. Acinar cell carcinoma was the histology with better prognosis at 10 years.
conclusionA decrease in the overall incidence of cases has been observed, which may be due to better diagnostic or registration accuracy along with changes in exposure to etiological factors such as smoking. Net survival at 10 years was 55.5% for the entire cohort.
Indexed as
Identifiers
42033612What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.